Japan Oligonucleotide Synthesis Market Report by Product, Application (PCR Primers, PCR Assays and Panels, Sequencing, DNA Microarrays, Fluorescence In-Situ Hybridization, Antisense Oligonucleotides, and Others), End Use, and Region 2024-2032

Description

Japan oligonucleotide synthesis market size is projected to exhibit a growth rate (CAGR) of 11.70% during 2024-2032. The widespread adoption of novel therapeutic strategies, coupled with significant growth of bioinformatics and data science, is primarily driving the market growth.

Oligonucleotide synthesis is the procedure for constructing short DNA or RNA molecules, known as oligonucleotides, with a specific sequence. These sequences can vary in length from just a few bases to approximately 200 nucleotides. This process is typically carried out through chemical synthesis in a controlled laboratory setting, often utilizing solid-phase phosphoramidite chemistry. In this approach, nucleotides are sequentially added to a growing chain, with each addition involving a series of chemical reactions. This technology allows scientists to create tailor-made oligonucleotides for a range of applications, including gene synthesis, polymerase chain reaction (PCR), gene editing tools like CRISPR-Cas9, and molecular diagnostic tests. Advances in oligonucleotide synthesis have greatly accelerated research in genomics and molecular biology, playing a pivotal role in numerous breakthroughs in medical and biological research.

Japan Oligonucleotide Synthesis Market Trends:

The Japanese market for oligonucleotides is primarily propelled by the increasing incidence of genetic diseases within the population. This necessitates the exploration of novel therapeutic approaches, with a significant role being played by oligonucleotide-based therapies. For example, therapies utilizing small interfering RNAs (siRNAs) and antisense oligonucleotides are being researched and applied in the treatment of genetic disorders like Duchenne muscular dystrophy and spinal muscular atrophy. Consequently, the growing prevalence of genetic diseases is driving demand not only in Japan but also on a wide scale. Furthermore, the expansion of bioinformatics and data science is directly impacting the oligonucleotide synthesis sector. The increasing capacity to analyze extensive genomic datasets is positively influencing the market by generating greater demand for the synthesis of innovative oligonucleotides. Additionally, oligonucleotides, particularly antisense oligonucleotides, have proven effective in epigenetic research and therapy, facilitating gene expression modulation and contributing to a favorable market outlook. Moreover, collaborations and partnerships between pharmaceutical companies, biotechnology firms, and research institutions have become crucial drivers in advancing the development and commercialization of oligonucleotide therapies for genetic diseases. These collaborative efforts are expected to fuel the regional market over the forecasted period.

Japan Oligonucleotide Synthesis Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product, application, and end use.

Product Insights:

Synthesized Oligonucleotide Products
Reagents
Equipment
Services

The report has provided a detailed breakup and analysis of the market based on the product. This includes synthesized oligonucleotide products, reagents, equipment, and services.

Application Insights:

PCR Primers
PCR Assays and Panels
Sequencing
DNA Microarrays
Fluorescence In-Situ Hybridization (FISH)
Antisense Oligonucleotides
Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in-situ hybridization (FISH), antisense oligonucleotides, and others.

End Use Insights:

Pharmaceutical and Biotechnology Companies
Hospital and Diagnostic Laboratories
Academic Research Institutes

The report has provided a detailed breakup and analysis of the market based on the end use. This includes pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic research institutes.

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region

The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan oligonucleotide synthesis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan oligonucleotide synthesis market?
What is the breakup of the Japan oligonucleotide synthesis market on the basis of product?
What is the breakup of the Japan oligonucleotide synthesis market on the basis of application?
What is the breakup of the Japan oligonucleotide synthesis market on the basis of end use?
What are the various stages in the value chain of the Japan oligonucleotide synthesis market?
What are the key driving factors and challenges in the Japan oligonucleotide synthesis?
What is the structure of the Japan oligonucleotide synthesis market and who are the key players?
What is the degree of competition in the Japan oligonucleotide synthesis market?

Product Code: SR112024A18546

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Oligonucleotide Synthesis Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Oligonucleotide Synthesis Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Oligonucleotide Synthesis Market - Breakup by Product

6.1 Synthesized Oligonucleotide Products
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Equipment
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)
6.4 Services
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2018-2023)
- 6.4.3 Market Forecast (2024-2032)

7 Japan Oligonucleotide Synthesis Market - Breakup by Application

7.1 PCR Primers
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 PCR Assays and Panels
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Forecast (2024-2032)
7.3 Sequencing
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2018-2023)
- 7.3.3 Market Forecast (2024-2032)
7.4 DNA Microarrays
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2018-2023)
- 7.4.3 Market Forecast (2024-2032)
7.5 Fluorescence In-Situ Hybridization (FISH)
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2018-2023)
- 7.5.3 Market Forecast (2024-2032)
7.6 Antisense Oligonucleotides
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2018-2023)
- 7.6.3 Market Forecast (2024-2032)
7.7 Others
- 7.7.1 Historical and Current Market Trends (2018-2023)
- 7.7.2 Market Forecast (2024-2032)

8 Japan Oligonucleotide Synthesis Market - Breakup by End Use

8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Forecast (2024-2032)
8.2 Hospital and Diagnostic Laboratories
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Academic Research Institutes
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)

9 Japan Oligonucleotide Synthesis Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2018-2023)
- 9.1.3 Market Breakup by Product
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End Use
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2024-2032)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2018-2023)
- 9.2.3 Market Breakup by Product
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End Use
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2024-2032)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2018-2023)
- 9.3.3 Market Breakup by Product
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End Use
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2024-2032)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2018-2023)
- 9.4.3 Market Breakup by Product
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End Use
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2024-2032)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2018-2023)
- 9.5.3 Market Breakup by Product
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End Use
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2024-2032)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2018-2023)
- 9.6.3 Market Breakup by Product
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End Use
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2024-2032)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2018-2023)
- 9.7.3 Market Breakup by Product
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End Use
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2024-2032)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2018-2023)
- 9.8.3 Market Breakup by Product
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End Use
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2024-2032)

10 Japan Oligonucleotide Synthesis Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

12 Japan Oligonucleotide Synthesis Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis